Trevi Therapeutics Announces Additions to the Senior Leadership Team
Key Management Appointments Support Company Growth as Lead Trials Move Towards Data New Haven, Conn., Aug 9, 2021 – Trevi
Key Management Appointments Support Company Growth as Lead Trials Move Towards Data New Haven, Conn., Aug 9, 2021 – Trevi
Detour bridges will help mitigate traffic disruption in heavily traveled area and allow for continual access to boat traffic on
Trevi Therapeutics Announces First Quarter 2020 Financial Results and Corporate Update
NEW HAVEN, Conn., April 08, 2020 (GLOBE NEWSWIRE) — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization
Enrollment in PRISM Study Progressing – Sample Size Re-estimation Planned for mid-2020 Expect to Report Top-Line Data in both PN
Investment in automation and industrial technology for the fenestration industry Wilton, CT, March 9, 2020 – Altus Capital Partners, an